Discovery of novel and selective SIRT6 inhibitors.

SIRT6 is an NAD(+)-dependent deacetylase with a role in the transcriptional control of metabolism and aging but also in genome stability and inflammation. Broad therapeutic applications are foreseen for SIRT6 inhibitors, including uses in diabetes, immune-mediated disorders, and cancer. Here we report on the identification of the first selective SIRT6 inhibitors by in silico screening. The most promising leads show micromolar IC50s, have significant selectivity for SIRT6 versus SIRT1 and SIRT2, and are active in cells, as shown by increased acetylation at SIRT6 target lysines on histone 3, reduced TNF-α secretion, GLUT-1 upregulation, and increased glucose uptake. Taken together, these results show the value of these compounds as starting leads for the development of new SIRT6-targeting therapeutic agents.

[1]  R. Mostoslavsky,et al.  The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease. , 2013, Current topics in medicinal chemistry.

[2]  S. Bruzzone,et al.  Editorial (Thematic Issue: NAD + Biosynthesis and Signaling as an Emerging Area in Medicinal Chemistry) , 2013 .

[3]  Tian Zhu,et al.  Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. , 2013, Journal of medicinal chemistry.

[4]  Yi Wang,et al.  Sirt6 regulates TNFα secretion via hydrolysis of long chain fatty acyl lysine , 2013, Nature.

[5]  Alberto Del Rio,et al.  Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives , 2012, Current pharmaceutical design.

[6]  A. Ballestrero,et al.  Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets , 2012, Current pharmaceutical design.

[7]  A. Regev,et al.  The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism , 2012, Cell.

[8]  G. Feldmann,et al.  The NAD+-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses* , 2012, The Journal of Biological Chemistry.

[9]  J. Denu,et al.  Sirtuin Catalysis and Regulation* , 2012, The Journal of Biological Chemistry.

[10]  F. Jiang,et al.  Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5. , 2012, The Journal of organic chemistry.

[11]  Alberto Del Rio,et al.  Freely accessible databases of commercial compounds for high- throughput virtual screenings. , 2012 .

[12]  S. Singhal,et al.  Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging , 2012, Molecular and Cellular Biochemistry.

[13]  Pierre Tufféry,et al.  The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections , 2011, Bioinform..

[14]  A. Seluanov,et al.  SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.

[15]  W. Sippl,et al.  Computer- and structure-based lead design for epigenetic targets. , 2011, Bioorganic & medicinal chemistry.

[16]  P. Pan,et al.  Structure and Biochemical Functions of SIRT6* , 2011, The Journal of Biological Chemistry.

[17]  Giuseppe Felice Mangiatordi,et al.  CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes. , 2010, Molecular bioSystems.

[18]  Oksana Gavrilova,et al.  SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice* , 2010, The Journal of Biological Chemistry.

[19]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[20]  Orian S. Shirihai,et al.  The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.

[21]  A. Ballestrero,et al.  Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE , 2009, PloS one.

[22]  C. Deng,et al.  Recent progress in the biology and physiology of sirtuins , 2009, Nature.

[23]  Véronique Kruys,et al.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner , 2009, Nature Medicine.

[24]  Howard Y. Chang,et al.  SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.

[25]  Olivier Sperandio,et al.  FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects , 2008, BMC Bioinformatics.

[26]  Howard Y. Chang,et al.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.

[27]  Pingfang Liu,et al.  Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.

[28]  C. Wolberger,et al.  Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. , 2005, Molecular cell.

[29]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[30]  Santosh A. Khedkar,et al.  Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. , 2010, Current topics in medicinal chemistry.